0 results for 'Allergan USA Inc'
No Tribal Immunity for Administrative Patent Challenges, PTAB Rules in Allergan Case
The decision ends—for now—a controversy that erupted last summer when Allergan paid the Saint Regis Mohawk Tribe to assume its Restasis patents in a creative legal strategy to fend off challengers.
Drugmakers Allege New Patent Infringement in Bid to Protect GI Treatment
Three pharmaceutical companies on Tuesday added another patent to an infringement suit against Sandoz Inc., as it tries to prevent a contingent of drugmakers from bringing generic versions of the gastrointestinal drug Linzess to market.
Skilled in the Art: Is PTAB Asking for 'Oil States' Trouble With Ruling on Sovereign Immunity?
By analogizing IPRs to district court litigation, a Patent Trial and Appeal Board panel led by Chief Judge David Ruschke just undercut its position in its Supreme Court fight for survival.
Opioid Crisis Costs: Is There a Cause of Action?
Paul Napoli and Marie Napoli write: There are several causes of action that the municipalities could bring to attempt to recover their damages resulting from the opioid epidemic.
Teva Accused of Infringing 10th Patent for Linzess
The makers of Linzess hit Teva Pharmaceuticals USA with another infringement suit Friday, accusing the Pennsylvania-based generic drugmaker of mounting a late challenge to a patent for the popular constipation drug.
Eye Drop Class Action Revived by Third Circuit
A putative class action over the size of eye medicine drops dismissed by a federal judge for lack of standing has been revived by the U.S. Court of Appeals for the Third Circuit.
States Expand Probe Into Big Pharma Opioid Marketing
New York and Massachusetts Attorneys General and 39 others announced Tuesday they are issuing subpoenas to several drug manufacturers in connection with the opioid and heroin abuse epidemic.
The Recorder Names the 2017 Corporate Departments of the Year
Gibson, Dunn & Crutcher has taken home the overall prize in The Recorder's Corporate Department of the Year contest, which honors firms whose California lawyers worked on the biggest, most complex and trendsetting deals this past year. Sidley Austin and Simpson Thacher & Bartlett, which both worked on blockbuster deals of their own, have been named finalists in the overall competition.
A Blast From the (Smoky) Past: Are Opioid Suits the New Big Tobacco?
As states, cities and counties pile on to sue opioid manufacturers for fueling drug addiction, it's got a familiar feeling: the suits against big tobacco.
Meet the Plaintiffs Lawyers Signing on to Help Gov'ts Sue Big Pharma Over Opioid Epidemic
A growing wave of plaintiffs lawyers are joining state and local governments in filing lawsuits against big pharmaceutical companies blaming them for the prescription opioid addiction epidemic and trying to recover taxpayer funds spent dealing with it.TRENDING STORIES
More from ALM
- Legal Speak at General Counsel Conference Midwest 2024: Carolyn Burbrink, Uber Director of Volume Mobility Safety and Insurance Litigation 1 minute read
- Legal Speak at General Counsel Conference Midwest 2024: Andy Goldberg, Laner Muchin Managing Partner 1 minute read
- Legal Speak at Legalweek 2024: Priori CEO and Co-Founder Basha Rubin; Shook, Hardy & Bacon Partner Patrick Oot 1 minute read
Resources
Revenue, Profit, Cash: Managing Law Firms for Success
Brought to you by Juris Ledger
Download Now
Law Firm Operational Considerations for the Corporate Transparency Act
Brought to you by Wolters Kluwer
Download Now
The Ultimate Guide to Remote Legal Work
Brought to you by Filevine
Download Now
Practical Guidance Journal: Protecting Work Product in a Generative AI World
Brought to you by LexisNexis®
Download Now